Healthcare -
Biotechnology - NASDAQ - US
$ 2.55
-1.16 %
$ 97.7 M
Market Cap
-1.55
P/E
Price Target
Average
115.69%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
27.05%
Net Income
Estimate
29.21%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Leap Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for LPTX of $5.5 , with forecasts ranging from
a
low of
$5.5 to a high of $5.5 .
LPTX Lowest Price Target
Wall Street Target
5.5 USD
115.69%
LPTX Average Price Target
Wall Street Target
5.5 USD
115.69%
LPTX Highest Price Target
Wall Street Target
5.5 USD
115.69%
REVENUE FORECAST
Revenue Forecast Chart LPTX
EBIT FORECAST
EBIT Forecast Chart LPTX
NET INCOME FORECAST
Net Income Chart LPTX